Literature DB >> 17434599

Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

Yong-Ku Kim1, Hyun-Gang Jung, Aye-Mu Myint, Hyun Kim, Sun-Hwa Park.   

Abstract

BACKGROUND: The role of cytokines in bipolar disorder is still controversial. Although a few studies have found alterations of cytokines in bipolar disorder, their findings were inconsistent. The aim of this study was to determine whether the cytokines are involved in the pathophysiology of bipolar disorder.
METHODS: A total of 37 manic patients with bipolar disorder and 74 control subjects were recruited. The mitogen-induced production of tumor necrosis factor (TNF)-alpha, interleukin-6 (IL-6), IL-4, interferon (IFN)-gamma, and IL-2 was measured using quantitative sandwich ELISA at the time of admission and 6 weeks after mood stabilizer treatment.
RESULTS: IL-6 and TNF-alpha production of bipolar manic patients was significantly higher than those of normal controls, while IL-4 values of the patients were significantly lower than normal controls. IL-6/IL-4, TNF-alpha/IL-4, IL-2/IL-4, and IFN-gamma/IL-4 ratios were significantly higher in bipolar manic patients than in normal controls. After 6 weeks of treatment, the levels of IL-6 significantly decreased compared with baseline. LIMITATIONS: The effect of various types of mood stabilizers on cytokine production should be considered.
CONCLUSIONS: These findings suggest that the increased activity of pro-inflammatory cytokines and an imbalance between pro-inflammatory and anti-inflammatory cytokines may play a role in the pathophysiology of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434599     DOI: 10.1016/j.jad.2007.02.018

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  99 in total

1.  Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Graziele Milioli; Jaqueline S Generoso; Andreza L Cipriano; Caroline S Costa; Ana Paula Moreira; Márcia Carvalho Vilela; Clarissa M Comim; Antonio Lucio Teixeira; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

Review 2.  Exercise and bipolar disorder: a review of neurobiological mediators.

Authors:  Mohammad T Alsuwaidan; Aaron Kucyi; Candy W Y Law; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

3.  Gender dysphoria: prejudice from childhood to adulthood, but no impact on inflammation. A cross-sectional controlled study.

Authors:  André Gonzales Real; Anna Martha Vaitses Fontanari; Angelo Brandelli Costa; Bianca Machado Borba Soll; Giovana Bristot; Larissa Fagundes de Oliveira; Ana Maria Kamphorst; Maiko Abel Schneider; Maria Inês Rodrigues Lobato
Journal:  Trends Psychiatry Psychother       Date:  2021-01-22

Review 4.  Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

Authors:  Robert K McNamara; Francis E Lotrich
Journal:  Expert Rev Neurother       Date:  2012-09       Impact factor: 4.618

5.  Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Barreto Huguet; Vanessa Amaral Mendonça; Lirlândia Pires Sousa; Fernando Silva Neves; Moisés Evandro Bauer; Antônio Lúcio Teixeira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-06       Impact factor: 5.270

6.  Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.

Authors:  Marcin Siwek; Magdalena Sowa-Kućma; Krzysztof Styczeń; Paulina Misztak; Rafał J Nowak; Bernadeta Szewczyk; Dominika Dudek; Janusz K Rybakowski; Gabriel Nowak; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-09-23       Impact factor: 5.590

Review 7.  The immunology of bipolar disorder.

Authors:  Izabela Guimarães Barbosa; Rodrigo Machado-Vieira; Jair C Soares; Antonio L Teixeira
Journal:  Neuroimmunomodulation       Date:  2014-02-14       Impact factor: 2.492

8.  Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.

Authors:  R Bruce Lydiard; Larry Culpepper; Helena Schiöler; Urban Gustafsson; Björn Paulsson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

9.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

10.  Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.

Authors:  Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.